IC
VTAE

Intel Corp’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Intel Corp’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$807K Buy
+105,751
New +$822K 1.98% 4

Other funds holding VTAE

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Intel Corp's VTAE Position: Q3 2014 in Review

Intel Corp opened a new position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2014: 105,751 shares worth $807K. The stake represents 1.98% of the portfolio and ranks #4 among its holdings.

15 funds tracked by Wall St. Rank hold VTAE as of Q3 2014.

  • Intel Corp held 105,751 shares of VITAE PHARMACEUTICALS INC COMMON STOCK worth $807K as of Q3 2014.
  • VITAE PHARMACEUTICALS INC COMMON STOCK was a new Intel Corp position in Q3 2014.
  • VITAE PHARMACEUTICALS INC COMMON STOCK made up 1.98% of Intel Corp's portfolio in Q3 2014, its #4 holding.
  • 15 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2014.

Based on Intel Corp's 13F filing for Q3 2014, filed 12 Nov 2014.